Hey all,Thought I'd chuck a bit of positivity around, if the...

Hey all,

Thought I'd chuck a bit of positivity around, if the trials are a complete success.

Let me take you back to 2 weeks ago to the Peer Review Ann.

"• The research article describes for the first-time that synthetic cannabidiol can also kill a select
group of Gram-negative bacteria, including the bacteria responsible for gonorrhoea, meningitis
and legionnaires disease
• New data also demonstrates the potential to develop novel structural analogs of cannabinoids
with increased antimicrobial activity providing a foundation for the development of a whole
new class of antimicrobials"

It also mentions a potential oral use.

Please correct me if I'm wrong, but BTX1801 is primarily targeting staph.
Just like many medical treatments, sometimes the first thought of use isn't exactly the endpoint of use.

If the trials aren't a success, I'll be topping up.
This isn't the end for BOT, but rather the beginning.
Enjoy the ride, it's out of our control for tonight.